Xpert MTB/RIFÀ» ÀÌ¿ëÇÑ °áÇÙ±Õ ¹× ¸®ÆÊÇÉ ³»¼º °Ë»çÀÇ À¯È¿¼º¿¡ ´ëÇÑ Ã¼°èÀû ¹®Çå°íÂû
A Systematic Review on the Effectiveness of Detection of M. tuberculosis and Rifampin Resistance Using Xpert MTB/RIF

´ëÇÑÀÓ»ó¹Ì»ý¹°ÇÐȸÁö 2014³â 17±Ç 2È£ p.42 ~ p.49

Á¤Áö¿µ(Jeong Ji-Young) - Çѱ¹º¸°ÇÀǷῬ±¸¿ø ½ÅÀÇ·á±â¼ú»ç¾÷º»ºÎ
À̼±Èñ(Lee Seon-Heui) - Çѱ¹º¸°ÇÀǷῬ±¸¿ø ½ÅÀÇ·á±â¼ú»ç¾÷º»ºÎ
Àå¼±¿µ(Jang Sun-Young) - ÇѼ­´ëÇб³ °£È£Çаú

Abstract

¹è°æ: Xpert MTB/RIF (Cepheid, USA)´Â ½Ç½Ã°£ ÀÌÁß ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀÀ» ÀÌ¿ëÇÏ¿© °áÇÙ±Õ °¨¿° ¿©ºÎ ¹× ¸®ÆÊÇÉ ³»¼º¿©ºÎ¸¦ µ¿½Ã¿¡ È®ÀÎÇÏ´Â °Ë»ç·Î °Ë»ç Á¤È®¼ºÀ» ÅëÇØ ÀÌ¿¡ ´ëÇÑ À¯È¿¼ºÀ» Æò°¡ÇÏ°íÀÚ ÇÑ´Ù.

¹æ¹ý: °áÇÙ±Õ °¨¿° ¹× ¸®ÆÊÇÉ ³»¼º ¿©ºÎÀÇ È®ÀÎÀÌ ÇÊ¿äÇÑ È¯ÀÚ¸¦ ´ë»óÀ¸·Î Xpert MTB/RIF°¡ ½ÃÇàµÈ ¹®ÇåÀ» ¼±ÅÃÇÏ¿©, Ç¥ÁØ°Ë»ç ´ëºñ °Ë»ç Á¤È®¼ºÀ» ÅëÇØ ÀÓ»óÀû À¯È¿¼ºÀ» Æò°¡ÇÏ¿´´Ù. ¹®Çå°Ë»öÀº 2011³â 8¿ù 16ÀÏ 1Â÷ °Ë»ö ½ÃÇà ÈÄ 10¿ù1ÀÏ ÃÖÁ¾°Ë»ö µÇ¾ú´Ù. ±¹³»¹®ÇåÀº KoreaMed¸¦ Áß½ÉÀ¸·Î 8°³ µ¥ÀÌÅͺ£À̽º, ±¹¿Ü¹®ÇåÀº Ovid-MEDLINE, Ovid-EMBASE ¹× Cochrane Library µîÀ» °Ë»öÇÏ¿´´Ù. ±¹³» ¹®ÇåÀº 130Æí, ±¹¿Ü ¹®ÇåÀº 1255ÆíÀ¸·Î ÃÑ 1385ÆíÀÌ °Ë»öµÇ¾ú´Ù. Áߺ¹µÈ ¹®Çå580ÆíÀ» Á¦¿ÜÇÑ 805ÆíÀ» Åä´ë·Î ¼±Åà ¹× ¹èÁ¦±âÁØÀ» Àû¿ëÇÏ¿© ±¹¿Ü¹®Çå 20ÆíÀ» Æò°¡¿¡ Æ÷ÇÔÇÏ¿´´Ù. ¹®Çå °Ë»öºÎÅÍ ¼±ÅñâÁØ Àû¿ë ¹× ÀÚ·áÃßÃâ±îÁö °¢ ´Ü°è´Â ¸ðµÎ Àü¹®°¡µé·Î ±¸¼ºµÈ ÀÚ¹®À§¿øµé°ú ´õºÒ¾î 2¸íÀÇ Æò°¡ÀÚ°¡ °¢ °úÁ¤À» µ¶¸³ÀûÀ¸·Î ¼öÇàÇÏ¿´´Ù. ¹®ÇåÀÇ Áú Æò°¡´Â SIGN (Scottish Intercollegiate Guidelines Network)ÀÇ µµ±¸¸¦ ÀÌ¿ëÇÏ¿´À¸¸ç, ÀÌ¿¡ µû¶ó±Ù°ÅÀÇ ¼öÁØ°ú ±Ç°íÀÇ µî±ÞÀ» ¼±Á¤ÇÏ¿© Æò°¡°á°ú¸¦ ±â¼úÇÏ¿´´Ù.

°á°ú: ù°, °áÇÙ±Õ °ËÃâ¿¡ ´ëÇÑ °Ë»çÁ¤È®¼ºÀº °áÇÙ±Õ ¹è¾ç °Ë»ç¸¦ ÂüÁ¶±âÁØÀ¸·Î ÇÏ¿© ÃÑ 20ÆíÀ¸·Î Æò°¡ÇÏ¿´´Ù. Ç×»ê±Õµµ¸» °Ë»ç °á°ú ¹× °ËüÀÇ Á¾·ù¸¦ °í·ÁÇÏÁö ¾ÊÀº Àüü °ËüÀÇ °æ¿ì ¹Î°¨µµ 0.69-1.00, ƯÀ̵µ 0.72-1.00, °Ë»çÁ¤È®µµ0.75-1.00À̾ú´Ù. µÑ°, ¸®ÆÊÇÉ ³»¼º¿¡ ´ëÇÑ °Ë»çÁ¤È®¼ºÀº ÃÑ 17ÆíÀ» ±Ù°Å·Î ÇÏ¿© Æò°¡ÇÏ¿´´Ù. Ç×°áÇÙÁ¦ °¨¼ö¼º °Ë»ç¸¦ÂüÁ¶±âÁØÀ¸·Î ÇÒ °æ¿ì Xpert MTB/RIFÀÇ ¹Î°¨µµ, ƯÀ̵µ, °Ë»çÁ¤È®µµ´Â °¢°¢ 0.75-1.00, 0.96-1.00, 0.95-1.00À̾ú´Ù.

°á·Ð: Xpert MTB/RIF´Â Ç¥ÁØ°Ë»ç¿Í ºñ±³½Ã Áø´ÜÁ¤È®¼ºÀÌ ¶Ù¾î³ª °áÇÙ±Õ °ËÃâ ¹× ¸®ÆÊÇÉ ³»¼ºÀÇ Áø´Ü¿¡ ÀÖ¾î ¾ÈÀüÇÏ°íÀ¯È¿ÇÑ °Ë»ç·Î ÆǴܵȴÙ.
Background: The purpose of this study was to evaluatethe effectiveness of Xpert MTB/RIF (Cepheid,USA) in the detection of Mycobacterium tuberculosis and to determine rifampin resistance.

Methods: The literature review covered the period from 16 August 2011 to 1 October 2011, and eight domestic databases and foreign databases including Ovid-Medline, Embase, and Cochrane Library were used. Key words, such as ¡®Rifampin, Polymerase Chain Reaction,¡¯ ¡®GeneXpert¡¯ and ¡®Xpert MTB-RIF¡¯were used to search a total of 1,385 documents. The SIGN (Scottish Intercollegiate Guidelines Network) tool was used to evaluate the quality of the 20 selected studies.

Results: Test accuracy for the detection of M. tuberculosis was assessed on the basis of 20 studies using the M. tuberculosis culture test as the reference standard. The acid-fast bacteria smearing test had a sensitivity in the range of 0.69-1.00, specificity in the range of 0.72-1.00 and test accuracy in the range of 0.75-1.00. Test accuracy regarding rifampin resistance was assessed on the basis of 17 studies.Using an anti-tuberculosis agent sensitivity test as the reference standard, the sensitivity, specificity and test accuracy of real-time, nested PCR were in the ranges of 0.75-1.00, 0.96-1.00 and 0.95-1.00, respectively.

Conclusion: Xpert MTB/RIF is a useful test for patients suspected of having rifampin-resistant tuberculosis.

Å°¿öµå

Meta-analysis, Multidrug-resistant, Polymerase chain reaction, Rifampin, Tuberculosis
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå